Last updated: November 22, 2023
Sponsor: Shaare Zedek Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gaucher Disease
Treatment
The investigators aim to identify prodromal PD in a cohort of carriers of Gaucher disease.
Clinical Study ID
NCT05253560
SZMC-0168-17
Ages 40-75 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Willing to participate
Exclusion
Exclusion Criteria:
- PD patients
- Dementia
Study Design
Total Participants: 600
Treatment Group(s): 1
Primary Treatment: The investigators aim to identify prodromal PD in a cohort of carriers of Gaucher disease.
Phase:
Study Start date:
May 16, 2017
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Michal Becker- Cohen
Jerusalem, Please Select... 9103102
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.